Robert C. Bast
No ORCID on file
· 7 papers in corpus
· active 1989-2025
Study types
- article 4
- review 2
- other 1
Condition tags
- endometriosis 4
Top journals
Frequent coauthors
article
2025
Abstract Introduction: Ovarian cancer remains the most fatal gynecologic malignancy. This grim reality stems primarily from the absence of effective early detection methods, resulting in most women receiving diagnoses at advanced stages. Un…
review
2012
More than 90% of ovarian cancers have been thought to arise from epithelial cells that cover the ovarian surface or, more frequently, line subserosal cysts. Recent studies suggest that histologically similar cancers can arise from the fimbr…
other
2012
OBJECTIVE: The human epididymis protein 4 (HE4) is a novel biomarker for ovarian cancer. This study measured the HE4 and CA125 levels in women with benign gynecological disorders. STUDY DESIGN: Sera were obtained from women prior to surger…
article
2011
Abstract At present, epithelial ovarian cancer is the leading killer among all gynecological malignancies. Despite much research, development of this neoplasm is still not fully understood. The five-year survival rate for this disease still…
article
2004
Early detection remains the most promising approach to improve long-term survival of patients with ovarian cancer. In a five-center case-control study, serum proteomic expressions were analyzed on 153 patients with invasive epithelial ovari…
article
1994
BACKGROUND: Endometrial carcinoma is generally diagnosed only after the onset of postmenopausal bleeding. Although most patients with Stage I disease can be cured, the prognosis worsens significantly when the tumor is no longer confined to …
review
1989
CA 125 is an antigenic determinant on a high-molecular-weight glycoprotein recognized by a monoclonal antibody which was raised using an ovarian cancer cell line as an immunogen. During the last 5 years the studies reviewed in this paper ha…